Contraceptive Advice for a Newly Married Couple

Criteria for an ideal method in this situation

• Highly effective but fully reversible
• No delay in return of fertility after stopping (rules out long-acting injectables as first choice)
• Minimal side effects, safe for young, healthy individuals
• Convenient and acceptable to both partners
• Provides protection from day one (no "learning curve" needed, unlike natural/fertility-awareness methods)

Recommended options

1. Barrier methods - condoms Simple, no systemic side effects, no effect on future fertility, and give added protection against STIs - a good "starter" method while the couple settles into married life and decides on a longer-term method.
2. Combined Oral Contraceptive Pills (COCs) Highly effective (>99% with correct use), fully reversible, fertility returns promptly on stopping, and offers non-contraceptive benefits (cycle regulation, reduced dysmenorrhea). Usually the preferred "spacing" method for a young woman with no contraindications (smoking, migraine with aura, thromboembolism risk, uncontrolled hypertension, etc.).
3. Copper IUCD (Cu-IUCD 375) Long-acting, highly effective, reversible, and can be used even in nulliparous women. Fertility returns immediately after removal. A good option once the couple wants a "set it and forget it" method without daily compliance.
4. Emergency contraception The couple should be counselled about emergency contraceptive pills as a backup, not a regular method.

Methods generally NOT advised as first choice

• Injectable progestins (DMPA) - effective, but return of fertility can be delayed 6-12 months after stopping, which is undesirable when the couple wants to conceive within a couple of years.
• Permanent sterilization (tubectomy/vasectomy) - inappropriate since the couple has not yet completed childbearing.
• Fertility awareness/rhythm methods alone - unreliable, especially early in marriage when cycles may not yet be well-tracked.

Public health context (India)

Bottom line

Advances in Management of Female Infertility - Short Notes (MS OBG)

Introduction

1. Advances in Ovulation Induction

• Letrozole (aromatase inhibitor) has emerged as first-line agent over clomiphene citrate for anovulatory infertility, especially in PCOS - associated with higher ovulation, pregnancy, and live birth rates than clomiphene (Legro et al.) - Berek & Novak's Gynecology
• Insulin sensitizers (metformin) used as adjunct in PCOS-related oligo-ovulation, alone or combined with clomiphene/letrozole
• Individualized gonadotropin protocols (low-dose step-up) to reduce OHSS and multiple pregnancy risk
• GnRH antagonist protocols replacing long agonist protocols in controlled ovarian stimulation - shorter duration, lower OHSS risk

2. Advances in Assisted Reproductive Technology (ART)

• Antagonist-based stimulation protocols with "freeze-all" strategy reduce OHSS risk
• Frozen embryo transfer (FET): vitrification techniques now give ~10% higher success rates than fresh transfer, allowing endometrial synchronization and avoiding hyperstimulated endometrium
• Time-lapse embryo imaging (EmbryoScope) and AI-driven embryo selection algorithms to improve selection of the most viable embryo without disturbing culture conditions
• Preimplantation Genetic Testing (PGT-A/PGT-M): improves live birth rates by up to 20% in women >37 years by screening for aneuploidy
• Non-invasive PGT (niPGT): uses cell-free DNA shed into culture media, avoiding embryo biopsy, with comparable accuracy
• In-vitro maturation (IVM) of immature oocytes - useful in PCOS, reduces gonadotropin exposure and OHSS risk
• ICSI advances for male factor co-existing infertility, combined with PICSI (physiological ICSI) and IMSI (high-magnification sperm selection)
• Donor oocyte and gestational carrier programs achieving 50-60% live birth rates in appropriate candidates

3. Advances in Surgical Management

• Hysteroscopic and laparoscopic fertility-sparing surgery: septum resection, myomectomy, adhesiolysis with reduced morbidity
• Robotic-assisted surgery for tubal reanastomosis and myomectomy with improved precision
• Improved management of endometriosis-associated infertility: laparoscopic excision vs ablation, with individualized decision on surgery vs direct ART based on ovarian reserve

4. Fertility Preservation

• Oocyte and embryo vitrification - flash-freezing technique markedly improved post-thaw survival compared to slow-freeze, now standard of care for fertility preservation (cancer patients, elective preservation)
• Ovarian tissue cryopreservation with re-transplantation - option for prepubertal or urgent oncology patients

5. Emerging / Investigational Therapies

• Ovarian rejuvenation therapy: autologous stem cell or platelet-rich plasma injection into ovaries aiming to stimulate egg production in diminished ovarian reserve - still experimental, evidence limited
• Endometrial regeneration using stem cells - being explored for recurrent implantation failure/thin endometrium
• AI-driven personalized stimulation protocols tailoring hormone dosage to patient-specific data
• Microbiome-based approaches (endometrial/vaginal microbiome analysis) to optimize implantation

6. Adjunctive and Holistic Management (evidence-based)

• Lifestyle interventions (weight optimization, exercise) - Cochrane/systematic review evidence supports benefit in improving natural conception and ART outcomes (PMID: 38743500)
• Psychological interventions (CBT, mindfulness) shown in recent systematic reviews/meta-analyses to reduce anxiety/depression in infertile women, though direct impact on pregnancy rates is less clear (PMID: 41121216, 38943413)
• Sleep and circadian health increasingly recognized as modifiable factor affecting fertility outcomes (PMID: 39707272)

Exam Tip Summary Table